abstract |
There is disclosed a pyrimidinecarboxamide compound useful as a pharmaceutical agent, synthetic processes, and pharmaceutical compositions which include the pyrimidinecarboxamide compound. More specifically, there is disclosed a CXCRl/2 inhibitor useful for treating a variety of inflammatory and neoplastic disorders. |